| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702917 | American Journal of Ophthalmology | 2017 | 19 Pages |
Abstract
VA was stable or improved in a majority of AIR patients while they were being treated with rituximab. OCT and ERG parameters, as well as AO-SLO cone densities, were stable during treatment. Studies with additional patients and longer follow-up periods are needed to further explore the utility of rituximab in the management of AIR.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Samaneh Davoudi, Nazanin Ebrahimiadib, Cagla Yasa, Damla D. Sevgi, Ramak Roohipoor, Evangelia Papavasilieou, Jason Comander, Lucia Sobrin,